Sabayton, Marilyn A.
HRN: 23-33-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2023
CIPROFLOXACIN 500MG (TAB)
07/14/2023
07/21/2023
PO
500 Mg
Bid
Acute Pyelonephritis
Waiting Final Action
Indication: Empiric Then Culture-directed Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes